, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
1 No. CC20200203ELE February 28, 2020 Subject Report of the Resolutions of Board of Directors’ Meeting No.1/2020 To President The Stock Exchange of Thailand The Board of Directors of Cal-Comp
June 30, 2019 To The President The Stock Exchange of Thailand Management’s Discussion and Analysis Consolidated Financial Statements For six months ended June 30, 2019 Overall Group Performance Table 1
วันที่ 10 พฤษภาคม พ -Translation- 1 Ref. LPN/SorKor/208/2561 9th August 2018 Re: Consolidated Financial Statements Analysis Q2/2018 Dear: President The Stock Exchange of Thailand L.P.N. Development
1 Translation CEN 001-2021 March 1, 2021 Subject Management Discussion and Analysis for the year 2020 To The Manager and President The Stock Exchange of Thailand Capital Engineering Network Public
: ..................................................... Attn: Secretary-General The Office of the Securities and Exchange Commission (SEC Office) We hereby wish to submit an application for registration / change of information in Company Account with details
quarter, the exchange rate of THB against US Dollar was weaken resulting to the Company had loss from exchange rate by THB 184 million. However, in the second quarter of 2018, the Company had the sale
Operation Date EBITDA Earnings before Interest, Tax, Depreciation and Amortization FX Foreign Exchange Rate IPP Independent Power Producer PPA Power Purchase Agreement SPP Small Power Producer Projects